Some clarifications on red meat and cancer

The evaluation on the carcinogenicity of red meat by the International Agency for Research on Cancer (IARC) – and not by WHO as many media reported – has given rise to a range of misunderstandings and is an example of how scientific communication on topics with a major public impact may prove extremely difficult.

When excellence comes home

Two aspects remain etched firmly after a talk with Andrea Lunardi and Graziano Martello, two "made in Italy" brains that have decided to return to work in Italy after years of research abroad. First, go abroad tout court is not an essential step; the difference is choosing centres of excellence abroad. Second: a PhD in Italy is a great resource, not to be missed, as long as you choose a good group to work with.

The "exposome" revolution arrives

Imagine about one thousand people equipped with smartphones which, in addition to the standard functions, serve to reveal using special sensors, pollutants, and which, thanks to GPS, correlate the findings whilst on the move. Now imagine that these same persons are monitored as part of an experiment where their blood and other bodily liquids are taken, dosing them with the main metabolites; the medical sphere monitors them and conducts surveys relying on questionnaires on primary lifestyle habits.

An antidiabetic drug to prevent and cure cancer

An old but effective drug against diabetes can also help in the fight against breast cancer. Probably, if administered to healthy women it can prevent its insurgence. These are the important results of a study on metformin just published on Nature Communication, and conducted by the team of Giovanni Blandino of the National Cancer Institute Regina Elena (IRCCS). In this work metformin exerts some of its antitumor activities by reprogramming the metabolism of a tumor cell.